The efficacy and safety of apatinib combined with S-1 for advanced gastric cancer: A systematic review and meta-analysis.

Xing ChenLifu WanYao HeQin ZhangXiaoyuan Zheng

Published in: Medicine (2024)

Apatinib combined with S-1 is more effective and safe for second-line and above treatment of AGC. This study minimized the conclusion bias caused by the basic data sources, but more high-quality studies are still needed to validate these conclusions.

Keyphrases

electronic health record
neoadjuvant chemotherapy
drinking water
big data
combination therapy
deep learning
locally advanced